Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad) Buy SOLV Stock  Free SOLV Stock Alerts

Solventum (SOLV) Financials

Solventum logo
$73.04 +0.43 (+0.59%)
Closing price 03:59 PM Eastern
Extended Trading
$73.09 +0.05 (+0.07%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Solventum

Annual Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 479 1,346 1,343
Consolidated Net Income / (Loss)		 479 1,346 1,343
Net Income / (Loss) Continuing Operations		 478 1,346 1,343
Total Pre-Tax Income 		605 1,667 1,692
Total Operating Income		 1,036 1,692 1,693
Total Gross Profit		 4,593 4,693 4,695
Total Revenue		 8,254 8,197 8,130
Operating Revenue		 8,254 8,197 8,130
Total Cost of Revenue		 3,661 3,504 3,435
Operating Cost of Revenue		 3,661 3,504 3,435
Total Operating Expenses		 3,557 3,001 3,002
Selling, General & Admin Expense		 2,782 2,243 2,235
Research & Development Expense		 775 758 767
Total Other Income / (Expense), net		 -431 -25 -1.00
Interest & Investment Income		 -367 0.00 0.00
Other Income / (Expense), net		 -64 -25 -1.00
Income Tax Expense		 127 321 349
Basic Earnings per Share		 $2.77 $7.79 $7.78
Weighted Average Basic Shares Outstanding		 173.20M 172.70M 172.70M
Diluted Earnings per Share		 $2.76 $7.79 $7.78
Weighted Average Diluted Shares Outstanding		 173.70M 172.70M 172.70M
Weighted Average Basic & Diluted Shares Outstanding		 172.99M - -

Quarterly Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Net Income / (Loss) Attributable to Common Shareholders		 31 122 89 237 272 460 321 293
Consolidated Net Income / (Loss)		 31 122 89 237 272 460 321 293
Net Income / (Loss) Continuing Operations		 30 122 89 237 272 460 321 293
Total Pre-Tax Income 		13 167 96 329 391 500 413 363
Total Operating Income		 136 275 244 381 406 504 417 365
Total Gross Profit		 1,119 1,165 1,137 1,172 1,158 1,209 1,189 1,137
Total Revenue		 2,075 2,082 2,081 2,016 2,036 2,074 2,076 2,011
Operating Revenue		 2,075 2,082 2,081 2,016 2,036 2,074 2,076 2,011
Total Cost of Revenue		 956 917 944 844 878 865 887 874
Operating Cost of Revenue		 956 917 944 844 878 865 887 874
Total Operating Expenses		 983 890 893 791 752 705 772 772
Selling, General & Admin Expense		 784 701 701 596 562 525 579 577
Research & Development Expense		 199 189 192 195 190 180 193 195
Total Other Income / (Expense), net		 -123 -108 -148 -52 -15 -4.00 -4.00 -2.00
Interest & Investment Income		 -107 -107 -114 -39 - 0.00 0.00 0.00
Other Income / (Expense), net		 -16 -1.00 -34 -13 -15 -4.00 -4.00 -2.00
Income Tax Expense		 -17 45 7.00 92 119 40 92 70
Basic Earnings per Share		 $0.19 $0.70 $0.51 $1.37 $1.57 $2.66 $1.86 $1.70
Weighted Average Basic Shares Outstanding		 173.20M 173.40M 173.20M 172.70M 172.70M 172.70M 172.70M 172.70M
Diluted Earnings per Share		 $0.18 $0.70 $0.51 $1.37 $1.57 $2.66 $1.86 $1.70
Weighted Average Diluted Shares Outstanding		 173.70M 173.90M 173.50M 172.70M 172.70M 172.70M 172.70M 172.70M
Weighted Average Basic & Diluted Shares Outstanding		 172.99M 172.75M 172.71M 172.71M 0.00 - - -

Annual Cash Flow Statements for Solventum

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents		 568 133 -30
Net Cash From Operating Activities		 1,185 1,915 1,679
Net Cash From Continuing Operating Activities		 1,185 1,915 1,679
Net Income / (Loss) Continuing Operations		 479 1,346 1,343
Consolidated Net Income / (Loss)		 479 1,346 1,343
Depreciation Expense		 555 561 578
Non-Cash Adjustments To Reconcile Net Income		 -419 24 101
Changes in Operating Assets and Liabilities, net		 570 -16 -343
Net Cash From Investing Activities		 -380 -230 -253
Net Cash From Continuing Investing Activities		 -380 -230 -253
Purchase of Property, Plant & Equipment		 -380 -290 -251
Divestitures		 0.00 60 0.00
Other Investing Activities, net		 0.00 0.00 -2.00
Net Cash From Financing Activities		 -240 -1,552 -1,460
Net Cash From Continuing Financing Activities		 -240 -1,552 -1,460
Repayment of Debt		 -292 1.00 -4.00
Issuance of Debt		 8,303 0.00 0.00
Other Financing Activities, net		 -8,251 -1,553 -1,456
Effect of Exchange Rate Changes		 3.00 0.00 4.00
Cash Interest Paid		 287 0.00 0.00
Cash Income Taxes Paid		 244 0.00 0.00

Quarterly Cash Flow Statements for Solventum

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Net Change in Cash & Equivalents		 -10 -125 -99 802 152 3.00 -4.00 -18
Net Cash From Operating Activities		 219 169 355 442 547 493 366 509
Net Cash From Continuing Operating Activities		 219 169 355 442 547 493 366 509
Net Income / (Loss) Continuing Operations		 31 122 89 237 272 460 321 293
Consolidated Net Income / (Loss)		 31 122 89 237 272 460 321 293
Depreciation Expense		 150 133 133 139 139 144 133 145
Non-Cash Adjustments To Reconcile Net Income		 -143 -126 -163 13 17 -40 19 28
Changes in Operating Assets and Liabilities, net		 181 40 296 53 119 -71 -107 43
Net Cash From Investing Activities		 -127 -93 -58 -102 -88 -6.00 -71 -65
Net Cash From Continuing Investing Activities		 -127 -93 -58 -102 -88 -6.00 -71 -65
Purchase of Property, Plant & Equipment		 -127 -93 -58 -102 -88 -66 -71 -65
Net Cash From Financing Activities		 -104 -202 -396 462 -306 -485 -299 -462
Net Cash From Continuing Financing Activities		 -104 -202 -396 462 -306 -485 -299 -462
Repayment of Debt		 -100 -202 - 10 -1.00 2.00 2.00 -2.00
Other Financing Activities, net		 -4.00 - -396 -7,851 -305 -487 -301 -460
Effect of Exchange Rate Changes		 2.00 1.00 - 0.00 -1.00 1.00 - 0.00

Annual Balance Sheets for Solventum

This table presents Solventum's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023
Period end date 12/31/2024 12/31/2023
Total Assets		 14,457 13,943
Total Current Assets		 3,249 2,519
Cash & Equivalents		 762 194
Accounts Receivable		 1,229 1,313
Inventories, net		 965 857
Other Current Assets		 293 155
Plant, Property, & Equipment, net		 1,622 1,457
Total Noncurrent Assets		 9,586 9,967
Goodwill		 6,377 6,535
Intangible Assets		 2,544 2,902
Other Noncurrent Operating Assets		 665 530
Total Liabilities & Shareholders' Equity		 14,457 13,943
Total Liabilities		 11,498 2,277
Total Current Liabilities		 2,703 1,728
Short-Term Debt		 200 0.00
Accounts Payable		 618 477
Accrued Expenses		 272 0.00
Current Deferred Revenue		 572 574
Other Current Liabilities		 1,041 677
Total Noncurrent Liabilities		 8,795 549
Long-Term Debt		 7,810 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 225 231
Noncurrent Employee Benefit Liabilities		 350 166
Other Noncurrent Operating Liabilities		 410 152
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 2,959 11,666
Total Preferred & Common Equity		 2,959 11,666
Total Common Equity		 2,959 11,666
Common Stock		 3,773 0.00
Retained Earnings		 242 0.00
Accumulated Other Comprehensive Income / (Loss)		 -1,056 -337
Other Equity Adjustments		 0.00 12,003

Quarterly Balance Sheets for Solventum

This table presents Solventum's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023
Total Assets		 14,457 14,745 14,578 14,711 13,943
Total Current Assets		 3,249 3,354 3,363 3,359 2,519
Cash & Equivalents		 762 772 897 996 194
Accounts Receivable		 1,229 1,327 1,317 1,220 1,313
Inventories, net		 965 953 899 901 857
Other Current Assets		 293 302 250 242 155
Plant, Property, & Equipment, net		 1,622 1,599 1,537 1,491 1,457
Total Noncurrent Assets		 9,586 9,792 9,678 9,861 9,967
Goodwill		 6,377 6,592 6,447 6,468 6,535
Intangible Assets		 2,544 2,651 2,724 2,810 2,902
Other Noncurrent Operating Assets		 665 549 507 583 530
Total Liabilities & Shareholders' Equity		 14,457 14,745 14,578 14,711 13,943
Total Liabilities		 11,498 11,553 11,711 10,860 2,277
Total Current Liabilities		 2,703 2,904 2,571 1,854 1,728
Short-Term Debt		 200 300 - - 0.00
Accounts Payable		 618 560 495 587 477
Accrued Expenses		 272 450 611 - 0.00
Current Deferred Revenue		 572 563 505 566 574
Other Current Liabilities		 1,041 1,031 960 701 677
Total Noncurrent Liabilities		 8,795 8,649 9,140 9,006 549
Long-Term Debt		 7,810 7,809 8,306 8,303 0.00
Noncurrent Deferred & Payable Income Tax Liabilities		 225 214 214 211 231
Noncurrent Employee Benefit Liabilities		 350 321 315 321 166
Other Noncurrent Operating Liabilities		 410 305 305 171 152
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,959 3,192 2,867 3,851 11,666
Total Preferred & Common Equity		 2,959 3,192 2,867 3,851 11,666
Total Common Equity		 2,959 3,192 2,867 3,851 11,666
Common Stock		 3,773 3,746 3,721 - 0.00
Retained Earnings		 242 211 89 - 0.00
Accumulated Other Comprehensive Income / (Loss)		 -1,056 -765 -943 -958 -337
Other Equity Adjustments		 0.00 0.00 0.00 4,809 12,003

Annual Metrics And Ratios for Solventum

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics		 - - -
Revenue Growth		 0.70% 0.82% 0.00%
EBITDA Growth		 -31.46% -1.85% 0.00%
EBIT Growth		 -41.69% -1.48% 0.00%
NOPAT Growth		 -40.09% 1.67% 0.00%
Net Income Growth		 -64.41% 0.22% 0.00%
EPS Growth		 -64.57% 0.13% 0.00%
Operating Cash Flow Growth		 -38.12% 14.06% 0.00%
Free Cash Flow Firm Growth		 120.62% 0.00% 0.00%
Invested Capital Growth		 -11.03% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -3.06% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 55.65% 57.25% 57.75%
EBITDA Margin		 18.50% 27.18% 27.92%
Operating Margin		 12.55% 20.64% 20.82%
EBIT Margin		 11.78% 20.34% 20.81%
Profit (Net Income) Margin		 5.80% 16.42% 16.52%
Tax Burden Percent		 79.17% 80.74% 79.37%
Interest Burden Percent		 62.24% 100.00% 100.00%
Effective Tax Rate		 20.99% 19.26% 20.63%
Return on Invested Capital (ROIC)		 7.55% 23.82% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -2.08% 44.63% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -1.00% -0.74% 0.00%
Return on Equity (ROE)		 6.55% 23.08% 0.00%
Cash Return on Invested Capital (CROIC)		 19.22% -176.18% 0.00%
Operating Return on Assets (OROA)		 6.85% 11.96% 0.00%
Return on Assets (ROA)		 3.37% 9.65% 0.00%
Return on Common Equity (ROCE)		 6.55% 23.08% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 16.19% 11.54% 0.00%
Net Operating Profit after Tax (NOPAT)		 819 1,366 1,344
NOPAT Margin		 9.92% 16.67% 16.53%
Net Nonoperating Expense Percent (NNEP)		 9.63% -20.81% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 7.46% 11.71% -
Cost of Revenue to Revenue		 44.35% 42.75% 42.25%
SG&A Expenses to Revenue		 33.70% 27.36% 27.49%
R&D to Revenue		 9.39% 9.25% 9.43%
Operating Expenses to Revenue		 43.09% 36.61% 36.93%
Earnings before Interest and Taxes (EBIT)		 972 1,667 1,692
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,527 2,228 2,270
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 3.86 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.38 0.00 0.00
Price to Earnings (P/E)		 23.82 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 4.20% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.83 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.26 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 12.22 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 19.20 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 22.80 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.75 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 8.96 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 2.71 0.00 0.00
Long-Term Debt to Equity		 2.64 0.00 0.00
Financial Leverage		 0.48 -0.02 0.00
Leverage Ratio		 1.94 1.20 0.00
Compound Leverage Factor		 1.21 1.20 0.00
Debt to Total Capital		 73.02% 0.00% 0.00%
Short-Term Debt to Total Capital		 1.82% 0.00% 0.00%
Long-Term Debt to Total Capital		 71.20% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 26.98% 100.00% 0.00%
Debt to EBITDA		 5.25 0.00 0.00
Net Debt to EBITDA		 4.75 0.00 0.00
Long-Term Debt to EBITDA		 5.11 0.00 0.00
Debt to NOPAT		 9.79 0.00 0.00
Net Debt to NOPAT		 8.85 0.00 0.00
Long-Term Debt to NOPAT		 9.54 0.00 0.00
Altman Z-Score		 1.46 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 1.20 1.46 0.00
Quick Ratio		 0.74 0.87 0.00
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 2,084 -10,106 0.00
Operating Cash Flow to CapEx		 311.84% 660.34% 668.92%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.58 0.59 0.00
Accounts Receivable Turnover		 6.49 6.24 0.00
Inventory Turnover		 4.02 4.09 0.00
Fixed Asset Turnover		 5.36 5.63 0.00
Accounts Payable Turnover		 6.69 7.35 0.00
Days Sales Outstanding (DSO)		 56.20 58.47 0.00
Days Inventory Outstanding (DIO)		 90.83 89.27 0.00
Days Payable Outstanding (DPO)		 54.59 49.69 0.00
Cash Conversion Cycle (CCC)		 92.45 98.05 0.00
Capital & Investment Metrics		 - - -
Invested Capital		 10,207 11,472 0.00
Invested Capital Turnover		 0.76 1.43 0.00
Increase / (Decrease) in Invested Capital		 -1,265 11,472 0.00
Enterprise Value (EV)		 18,660 0.00 0.00
Market Capitalization		 11,412 0.00 0.00
Book Value per Share		 $17.13 $67.55 $0.00
Tangible Book Value per Share		 ($34.51) $12.91 $0.00
Total Capital		 10,969 11,666 0.00
Total Debt		 8,010 0.00 0.00
Total Long-Term Debt		 7,810 0.00 0.00
Net Debt		 7,248 -194 0.00
Capital Expenditures (CapEx)		 380 290 251
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -16 597 0.00
Debt-free Net Working Capital (DFNWC)		 746 791 0.00
Net Working Capital (NWC)		 546 791 0.00
Net Nonoperating Expense (NNE)		 340 20 0.79
Net Nonoperating Obligations (NNO)		 7,248 -194 0.00
Total Depreciation and Amortization (D&A)		 555 561 578
Debt-free, Cash-free Net Working Capital to Revenue		 -0.19% 7.28% 0.00%
Debt-free Net Working Capital to Revenue		 9.04% 9.65% 0.00%
Net Working Capital to Revenue		 6.62% 9.65% 0.00%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $2.77 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 173.20M 0.00 0.00
Adjusted Diluted Earnings per Share		 $2.76 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 173.70M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 172.99M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 819 1,366 1,344
Normalized NOPAT Margin		 9.92% 16.67% 16.53%
Pre Tax Income Margin		 7.33% 20.34% 20.81%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Solventum

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Growth Metrics		 - - - - - - - -
Revenue Growth		 1.92% 0.39% 0.24% 0.25% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -49.06% -36.80% -37.18% -0.20% 0.00% 0.00% 0.00% 0.00%
EBIT Growth		 -69.31% -45.20% -49.15% 1.38% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth		 11.12% -56.67% -30.21% -6.84% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 -88.60% -73.48% -72.27% -19.11% 0.00% 0.00% 0.00% 0.00%
EPS Growth		 -88.54% -73.68% -72.58% -19.41% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -59.96% -65.72% -3.01% -13.16% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 -11.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 -0.34% 0.05% 3.22% 0.00% -1.83% -0.10% 3.23% 0.00%
EBITDA Q/Q Growth		 -33.66% 18.66% -32.35% 0.00% -17.70% 17.95% 7.48% 0.00%
EBIT Q/Q Growth		 -56.20% 30.48% -42.93% 0.00% -21.80% 21.07% 13.77% 0.00%
NOPAT Q/Q Growth		 56.22% -11.19% -17.58% 0.00% -39.09% 43.06% 10.01% 0.00%
Net Income Q/Q Growth		 -74.59% 37.08% -62.45% 0.00% -40.87% 43.30% 9.56% 0.00%
EPS Q/Q Growth		 -74.29% 37.25% -62.77% 0.00% -40.98% 43.01% 9.41% 0.00%
Operating Cash Flow Q/Q Growth		 29.59% -52.39% -19.68% 0.00% 10.95% 34.70% -28.09% 0.00%
Free Cash Flow Firm Q/Q Growth		 115.29% -2.77% 7.66% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -3.06% 2.46% -7.90% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 53.93% 55.96% 54.64% 58.13% 56.88% 58.29% 57.27% 56.54%
EBITDA Margin		 13.01% 19.55% 16.48% 25.15% 26.03% 31.05% 26.30% 25.26%
Operating Margin		 6.55% 13.21% 11.73% 18.90% 19.94% 24.30% 20.09% 18.15%
EBIT Margin		 5.78% 13.16% 10.09% 18.25% 19.20% 24.11% 19.89% 18.05%
Profit (Net Income) Margin		 1.49% 5.86% 4.28% 11.76% 13.36% 22.18% 15.46% 14.57%
Tax Burden Percent		 238.46% 73.05% 92.71% 72.04% 69.57% 92.00% 77.72% 80.72%
Interest Burden Percent		 10.83% 60.95% 45.71% 89.40% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 -130.77% 26.95% 7.29% 27.96% 30.43% 8.00% 22.28% 19.28%
Return on Invested Capital (ROIC)		 11.52% 0.00% 0.00% 0.00% 9.91% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.50% 0.00% 0.00% 0.00% 15.29% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 1.69% 0.00% 0.00% 0.00% -0.25% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 13.20% 0.00% 0.00% 0.00% 9.66% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 19.22% 0.00% 0.00% 0.00% -88.09% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 3.36% 0.00% 0.00% 0.00% 11.29% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.87% 0.00% 0.00% 0.00% 7.85% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 13.20% 0.00% 0.00% 0.00% 9.66% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 314 201 226 274 282 464 324 295
NOPAT Margin		 15.13% 9.65% 10.87% 13.61% 13.87% 22.36% 15.61% 14.65%
Net Nonoperating Expense Percent (NNEP)		 8.02% 2.15% 3.70% 1.03% -5.38% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 2.86% - - - 2.42% - - -
Cost of Revenue to Revenue		 46.07% 44.04% 45.36% 41.87% 43.12% 41.71% 42.73% 43.46%
SG&A Expenses to Revenue		 37.78% 33.67% 33.69% 29.56% 27.60% 25.31% 27.89% 28.69%
R&D to Revenue		 9.59% 9.08% 9.23% 9.67% 9.33% 8.68% 9.30% 9.70%
Operating Expenses to Revenue		 47.37% 42.75% 42.91% 39.24% 36.94% 33.99% 37.19% 38.39%
Earnings before Interest and Taxes (EBIT)		 120 274 210 368 391 500 413 363
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 270 407 343 507 530 644 546 508
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 3.86 3.77 3.19 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 23.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.83 1.84 1.61 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 12.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 19.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 22.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 8.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 2.71 2.54 2.90 2.16 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 2.64 2.45 2.90 2.16 0.00 0.00 0.00 0.00
Financial Leverage		 0.48 2.30 2.58 1.90 -0.02 0.00 0.00 0.00
Leverage Ratio		 1.94 4.62 5.08 3.82 1.20 0.00 0.00 0.00
Compound Leverage Factor		 0.21 2.82 2.32 3.42 1.20 0.00 0.00 0.00
Debt to Total Capital		 73.02% 71.75% 74.34% 68.32% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 1.82% 2.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 71.20% 69.10% 74.34% 68.32% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 26.98% 28.25% 25.66% 31.69% 100.00% 0.00% 0.00% 0.00%
Debt to EBITDA		 5.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 4.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 5.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 9.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 8.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 9.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 1.26 0.74 0.59 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 1.20 1.16 1.31 1.81 1.46 0.00 0.00 0.00
Quick Ratio		 0.74 0.72 0.86 1.20 0.87 0.00 0.00 0.00
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,579 -10,328 -10,050 -10,884 0.00 0.00 0.00 0.00
Operating Cash Flow to CapEx		 172.44% 181.72% 612.07% 433.33% 621.59% 746.97% 515.49% 783.08%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.58 0.00 0.00 0.00 0.59 0.00 0.00 0.00
Accounts Receivable Turnover		 6.49 0.00 0.00 0.00 6.24 0.00 0.00 0.00
Inventory Turnover		 4.02 0.00 0.00 0.00 4.09 0.00 0.00 0.00
Fixed Asset Turnover		 5.36 0.00 0.00 0.00 5.63 0.00 0.00 0.00
Accounts Payable Turnover		 6.69 0.00 0.00 0.00 7.35 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 56.20 0.00 0.00 0.00 58.47 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 90.83 0.00 0.00 0.00 89.27 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 54.59 0.00 0.00 0.00 49.69 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 92.45 0.00 0.00 0.00 98.05 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 10,207 10,529 10,276 11,158 11,472 0.00 0.00 0.00
Invested Capital Turnover		 0.76 0.00 0.00 0.00 0.71 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -1,265 10,529 10,276 11,158 0.00 0.00 0.00 0.00
Enterprise Value (EV)		 18,660 19,378 16,542 0.00 0.00 0.00 0.00 0.00
Market Capitalization		 11,412 12,041 9,133 0.00 0.00 0.00 0.00 0.00
Book Value per Share		 $17.13 $18.48 $16.60 $22.30 $67.55 $0.00 $0.00 $0.00
Tangible Book Value per Share		 ($34.51) ($35.04) ($36.50) ($31.42) $12.91 $0.00 $0.00 $0.00
Total Capital		 10,969 11,301 11,173 12,154 11,666 0.00 0.00 0.00
Total Debt		 8,010 8,109 8,306 8,303 0.00 0.00 0.00 0.00
Total Long-Term Debt		 7,810 7,809 8,306 8,303 0.00 0.00 0.00 0.00
Net Debt		 7,248 7,337 7,409 7,307 -194 0.00 0.00 0.00
Capital Expenditures (CapEx)		 127 93 58 102 88 66 71 65
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -16 -22 -105 509 597 0.00 0.00 0.00
Debt-free Net Working Capital (DFNWC)		 746 750 792 1,505 791 0.00 0.00 0.00
Net Working Capital (NWC)		 546 450 792 1,505 791 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 283 79 137 37 10 3.68 3.11 1.61
Net Nonoperating Obligations (NNO)		 7,248 7,337 7,409 7,307 -194 0.00 0.00 0.00
Total Depreciation and Amortization (D&A)		 150 133 133 139 139 144 133 145
Debt-free, Cash-free Net Working Capital to Revenue		 -0.19% 0.00% 0.00% 0.00% 7.28% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 9.04% 0.00% 0.00% 0.00% 9.65% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 6.62% 0.00% 0.00% 0.00% 9.65% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.19 $0.70 $0.51 $1.37 $1.57 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 173.20M 173.40M 173.20M 172.70M 172.70M 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.18 $0.70 $0.51 $1.37 $1.57 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 173.70M 173.90M 173.50M 172.70M 172.70M 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 172.99M 172.75M 172.71M 172.71M 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 95 201 226 274 282 464 324 295
Normalized NOPAT Margin		 4.59% 9.65% 10.87% 13.61% 13.87% 22.36% 15.61% 14.65%
Pre Tax Income Margin		 0.63% 8.02% 4.61% 16.32% 19.20% 24.11% 19.89% 18.05%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Solventum's Financials

When does Solventum's fiscal year end?

According to the most recent income statement we have on file, Solventum's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Solventum's net income changed over the last 2 years?

Solventum's net income appears to be on a downward trend, with a most recent value of $479 million in 2024, falling from $1.34 billion in 2022. The previous period was $1.35 billion in 2023. Find out what analysts predict for Solventum in the coming months.

What is Solventum's operating income?
Solventum's total operating income in 2024 was $1.04 billion, based on the following breakdown:
  • Total Gross Profit: $4.59 billion
  • Total Operating Expenses: $3.56 billion
How has Solventum revenue changed over the last 2 years?

Over the last 2 years, Solventum's total revenue changed from $8.13 billion in 2022 to $8.25 billion in 2024, a change of 1.5%.

How much debt does Solventum have?

Solventum's total liabilities were at $11.50 billion at the end of 2024, a 405.0% increase from 2023, and a 405.0% increase since 2023.

How much cash does Solventum have?

In the past 1 years, Solventum's cash and equivalents has ranged from $194 million in 2023 to $762 million in 2024, and is currently $762 million as of their latest financial filing in 2024.

How has Solventum's book value per share changed over the last 2 years?

Over the last 2 years, Solventum's book value per share changed from 0.00 in 2022 to 17.13 in 2024, a change of 1,712.8%.


Related Companies

This page (NYSE:SOLV) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...
Brownstone Research | Sponsored
Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...
Golden Portfolio | Sponsored
Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...
Crypto 101 Media | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
HISTORIC Gold Move Sends Flashing Red Signal To 401K Savers
Historically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...
Colonial Metals | Sponsored
We’ve Entered the Most Bullish Phase of the Cycle
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored